Ijlal Erturan

Ijlal Erturan

Auto-generated profile, based on publicly available information

Ijlal Erturan

Department of Dermatology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
MŞMümtaz Cem Şirin
Mümtaz Cem Şirin
SKSelma Korkmaz
Selma Korkmaz
IEIjlal Erturan
Ijlal Erturan
BFBasak Filiz
Basak Filiz
BABuket Cicioglu Aridogan
Buket Cicioglu Aridogan
MYMehmet Yildirim
Mehmet Yildirim
Psoriasis is a chronic systemic inflammatory disease frequently associated with serious comorbidities. To investigate the systemic inflammatory burden in psoriasis and to assess the correlation between traditional and novel inflammatory markers and the severity of the disease. This cross-sectional study was conducted on 60 patients with psoriasis vulgaris and 50 healthy volunteers. Data including demographics, Psoriasis Area and Severity Index scores, and laboratory results were analyzed and compared. Compared with the control group, the psoriatic patients had significantly higher high sensitive C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, leukocyte, neutrophil, neutrophil-to-lymphocyte ratio, monocyte to high density lipoprotein (HDL) cholesterol ratio, and aspartate aminotransferase levels, and significantly lower HDL cholesterol levels (p < 0.05). No significant difference was found in procalcitonin, lymphocyte, monocyte, hemoglobin, red blood cell distribution width, platelet, mean platelet volume, platelet distribution width, lymphocyte-to-monocyte ratio, anti-cyclic citrullinated peptide, glucose, alanine aminotransaminase, blood urea nitrogen, creatinine, triglyceride, total cholesterol, and LDL cholesterol levels between the two groups (p > 0.05). The Psoriasis Area and Severity Index score was positively correlated with high-sensitivity C-reactive protein, serum amyloid A, and monocyte to HDL cholesterol ratio, and negatively correlated with lymphocyte-to-monocyte ratio (p < 0.05). This was a single-center study with relatively limited numbers of patients and controls. The data show that high sensitivity C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, neutrophil-to-lymphocyte ratio, and monocyte to HDL cholesterol ratio can be used as markers of systemic inflammation in patients with psoriasis. Moreover, high sensitivity C-reactive protein, serum amyloid A, monocyte to HDL cholesterol ratio and lymphocyte-to-monocyte ratio are closely related to the Psoriasis Area and Severity Index score, and they may be regarded as objective indicators in determining the disease severity.



14 February 2014 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
IEİjlal Erturan
İjlal Erturan
BKBanu Kale Köroğlu
Banu Kale Köroğlu
AAAli Adiloğlu
Ali Adiloğlu
ACAli M. Ceyhan
Ali M. Ceyhan
VAVahide B. Akkaya
Vahide B. Akkaya
OKOsman Kılınç
Osman Kılınç

1 January 2014 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
PBPinarYuksel Basak
PinarYuksel Basak
IEIjlal Erturan
Ijlal Erturan
OYOzlem Yuksel
Ozlem Yuksel
OKOyaOylum Kazanoglu
OyaOylum Kazanoglu
HVHuseyin Vural
Huseyin Vural

24 October 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BFBaşak FİLİZ
Başak FİLİZ
MYMehmet Yildirim
Mehmet Yildirim
KÖKuyaş HEKİMLER ÖZTÜRK
Kuyaş HEKİMLER ÖZTÜRK
FŞFevziye Burcu Şi̇rİn
Fevziye Burcu Şi̇rİn
SÇSeda Çeli̇k
Seda Çeli̇k
HOHikmet Orhan
Hikmet Orhan
IL-23R gene polymorphisms and the association of these polymorphisms with serum IL-23 levels were investigated in patients with psoriasis in the current study. Sixty-seven patients with psoriasis who were admitted to our dermatology outpatient clinic and 67 healthy controls were included in the study. Polymorphisms of the IL-23R gene were determined by KASP-PCR method, and serum IL-23 levels were determined by ELISA method. The distribution of IL-23R gene polymorphisms rs2201841, rs11209026, rs7530511, rs1343152, and rs11465804 was not significantly different in the patient and control groups. The AA genotype of the rs2201841 locus in males and the GA genotype in females, as well as the AA genotype of the rs1343152 locus in males and the CA genotype in females, were statistically significant in patients with psoriasis. The mean serum IL-23 level was significantly lower in the patient group (42.62 ± 5.96) compared to the control groups (75.76 ± 13.24). IL-23R gene polymorphisms including rs2201841, rs11209026, rs7530511, rs11465804, and rs1343152 were not found to be significantly related to psoriasis. Different genetic polymorphisms may play a role in the development of psoriasis in female and male populations. Ethnic differences between different populations may have led to differences in the distribution of polymorphisms in the current study with compared to other published studies. Additionally, many different genes, polymorphisms, and environmental factors that have an effect on the development of psoriasis may affect the disease process.